RVC Investor Update & New Round Deep Dive with Vaporox

When
Thursday, June 08, 2023
3:30 PM - 5:00 PM
Location
Hypbrid: In-person at Vaporox Headquarters (8375 Willow St, Lone Tree, CO 80124) or virtually via Zoom Conference Call -- Details Shared w/ Registrants
Spaces left
19

Registration

(depends on selected options)

Base fee:

Investor or Fund Manager (Active Investor Member)
Investor or Fund Manager (non-member)

Registration is closed

RVC Investor Update & Deep Dive w/ Vaporox

Hypbrid: In-person at Vaporox Headquarters (8375 Willow St, Lone Tree, CO 80124) or virtually via Zoom Conference Call -- Details Shared w/ Registrants

Vaporox is commercializing Vaporous Hyperoxia Therapy (VHT™). This patented technology represents a breakthrough in treating diabetic foot ulcers (DFUs) and other chronic wounds. VHT is a Low-Frequency, Non-Contact, Non-Thermal Ultrasound Treatment. VHT is FDA-cleared technology that has been clinically validated as a safe and effective adjunctive treatment for healing nine types of skin wounds.

The purpose of this meeting is to meet face-to-face with the company CEO and leadership in order to get crucial questions answered. The Deep Dive will take place in Denver and will cover all the major due diligence questions such as IP, competition, leadership, funding strategy, exit strategy, use of funds, milestones, etc.

The format for the Deep Dive will be as follows:

Company Update & Q&A w/ Investors (1 hour)

Outstanding Questions w/ Company (30 minutes)

_____________________________________________

Deep Dive

Time: 3:30pm to 5:00pm MT

__________________________________________

To attend, you must be an accredited investor (net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 together with his or her spouse if married] and have the expectation to make the same amount this year). We do not require a minimum investment.